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Production of type I interferons (IFN-I) is a crucial
innate immune mechanism against viral infections.
IFN-I induction is subject to negative regulation by
both viral and cellular factors, but the underlying
mechanism remains unclear. We report that the non-
canonical NF-kB pathway was stimulated along with
innate immune cell differentiation and viral infections
and had a vital role in negatively regulating IFN-I
induction. Genetic deficiencies in major components
of the noncanonical NF-kB pathway caused IFN-I
hyperinduction and rendered cells and mice sub-
stantially more resistant to viral infection. Noncanon-
ical NF-kB suppressed signal-induced histone
modifications at the Ifnb promoter, an action that
involved attenuated recruitment of the transcription
factor RelA and a histone demethylase, JMJD2A.
These findings reveal an unexpected function of
the noncanonical NF-kB pathway and highlight an
important mechanism regulating antiviral innate
immunity.
INTRODUCTION
Innate immunity serves as the first line of host defense against
invading microorganisms. In response to an infection, germ-
line-encoded pattern recognition receptors (PRRs), such as
toll-like receptors (TLRs) and RIG-I-like receptors, detect path-
ogen-associated molecular patterns and rapidly induce the
production of proinflammatory cytokines and type I interferons
(IFN-Is) (Dunn et al., 2006; Kawai and Akira, 2006). The IFN-Is,
including IFN-a and IFN-b, are produced in various cell types,
such as macrophages, dendritic cells (DCs), and fibroblasts,
and function as critical effector molecules in an innate immune
response against viral infections (Stetson and Medzhitov,
2006). Under normal conditions, the induction of IFN-Is is under
tight control, because their deregulated production may pro-
mote the development of immunological disorders under certain
circumstances (Trinchieri, 2010). Moreover, viruses have mech-342 Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc.anisms to negatively regulate IFN-I induction, therebyweakening
the innate immune responses (Katze et al., 2002). However, the
molecular mechanisms that negatively control IFN-I induction
remain incompletely understood.
Induction of IFN-Is involves a signaling pathway leading to the
activation of two homologous kinases, TBK1 and IKKε, and the
subsequent activation of the transcription factors IFN-regulatory
factor 3 (IRF3) and IRF7 (Fitzgerald et al., 2003; Sharma et al.,
2003). In addition, the IFN gene induction also requires NF-kB,
which cooperates with IRF3 and IRF7 in the assembly of an en-
hanceosome in the IFN-b promoter and the recruitment of coac-
tivators and chromatin-remodeling factors (Bartlett et al., 2012;
Falvo et al., 2000; Panne et al., 2007; Wang et al., 2010).
NF-kB represents a family of transcription factors, including
RelA, RelB, c-Rel, NF-kB1 p50, and NF-kB2 p52, which can be
activated by canonical and noncanonical pathways (Hayden
and Ghosh, 2008; Sun, 2012; Vallabhapurapu and Karin, 2009).
The canonical NF-kB members, which typically include p50-
RelA and p50-c-Rel heterodimers, are activated by various
immune receptors and are known to participate in the induction
of IFN-Is and proinflammatory cytokines (Hayden and Ghosh,
2008; Wang et al., 2010). In contrast, the noncanonical NF-kB,
the p52-RelB dimer, is thought to respond to selective receptor
signals that mediate adaptive immune functions, such as
lymphoid organ development and B cell survival (Sun, 2012). A
central step in noncanonical NF-kB signaling is stabilization of
the protein kinase NIK (Liao et al., 2004), which, together with
its downstream kinase IKKa, induce phosphorylation-dependent
processing of p100, an NF-kB precursor protein that also func-
tions as a cytoplasmic inhibitor of NF-kB (Senftleben et al.,
2001; Sun, 2012; Xiao et al., 2001). Under normal conditions,
the signaling function of NIK is suppressed through its constant
degradation by a TRAF3-dependent mechanism that involves
recruitment of NIK to the E3 ubiquitin ligase c-IAP1 or c-IAP2
(Liao et al., 2004; Vallabhapurapu et al., 2008; Zarnegar et al.,
2008). Signal-induced noncanonical NF-kB activation involves
ubiquitin-dependent degradation of TRAF3 and accumulation
of NIK (Sun, 2012).
Although the noncanonical NF-kB pathway plays a crucial role
in the regulation of lymphoid organ development and adaptive
immunity, it is currently unclear whether this pathway also has
a role in the regulation of innate immunity. In the present study,
we discovered an unexpected role for the noncanonical NF-kB
Figure 1. NIK Deficiency Potentiates Antiviral Immunity
(A–C) Age-matched (6–8 weeks old) WT and Map3k14–/– mice, bred to the Rag1–/– background, were infected i.v. with VSV (2 3 107 PFU per mouse). Data are
presented as mean ± SD of six animals.
(A) Survival curves (n = 12).
(B) Tissue VSV titers on day 3 of infection.
(C) Serum concentrations of IFN-a and IFN-b at 12 hr of infection.
(D and E) WT andMap3k14–/– mice, bred to theRag1–/–-Ifnar1–/– background, were infected i.v. with VSV (23 107 PFU per mouse). Data are presented asmean ±
SD of six animals.
(D) Survival curves (n = 6).
(E) Tissue VSV titers on day 3 of infection.
(F) WT orMap3k14–/– primary MEFs were infected with GFP-expressing VSV (VSV-GFP) at a MOI of 0.1 for 24 hr. Data are presented as a representative picture,
showing the infected (GFP+) and total (bright field) cells (left). Scale bar represents 1,000 mm. The summary graph of flow cytometric quantification of the infected
cells (right). Data are representative of three independent experiments, and statistical analyses represent variations in technical replicates. *p < 0.05.
See also Figure S1.
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Noncanonical NF-kB Regulates IFN-I inductionpathway in the negative regulation of IFN-I induction. Genetic
deficiency in the signaling components of this pathway caused
IFN-I hyperinduction, whereas the deregulated activation of non-
canonical NF-kB contributed to the attenuated IFN-I induction.
The noncanonical NF-kB regulated histone modifications at the
Ifnb promoter, which involved attenuated recruitment of the
canonical NF-kB RelA and a histone demethylase, JMJD2A, to
the Ifnb promoter. These findings reveal an unexpected mecha-
nism that controls type I IFN induction and establish a crucial
regulatory role of the noncanonical NF-kB pathway in antiviral
innate immunity.
RESULTS
NIK Is a Negative Regulator of Antiviral Innate Immunity
Because NIK is a central component of the noncanonical NF-kB
pathway, we examined the role of NIK in the regulation of innate
immunity against viral infections. We crossed Map3k14–/– mice
(deficient in the NIK-encoding gene Map3k14) onto Rag1–/–
background to eliminate their adaptive cellular components
and lymphocytes and challenged themwith a well-characterized
viral pathogen, the vascular stomatitis virus (VSV). Interestingly,the Map3k14–/– mice were substantially more resistant to VSV
infection than were Map3k14+/+ (wild-type, or WT) mice, as
shown by increased survival rate (Figure 1A) and reduced viral
load in different organs (Figure 1B). Moreover, the Map3k14–/–
mice produced significantly more IFN-a and IFN-b (Figure 1C).
The elevated IFN-I production contributed to the VSV-resistance
phenotype of the Map3k14–/– mice, as indicated by the fact
that the Map3k14–/– and WT mice displayed similar sensitivity
to VSV infection when crossed to the Infar1–/– background (Fig-
ures 1D and 1E). In the Infar1–/– background, NIK deficiency
promoted the production of IFN-b but not IFN-a (Figure S1A
available online). IFN-b-stimulated IFNAR1 signaling is known
to mediate IFN-a induction (Asano et al., 1990; Marie´ et al.,
1998), so these results indicate that the effect of NIK deficiency
on IFN-a induction may involve the autocrine action of IFN-b. To
further confirm that NIK negatively regulates antiviral innate
immunity, we performed in vitro experiments with control
and Map3k14–/– mouse embryonic fibroblasts (MEFs). The
Map3k14–/– MEFs were substantially more resistant to VSV
infection in vitro than the WT MEFs (Figure 1F). These results
suggest a negative role for NIK in regulating antiviral innate
immunity.Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc. 343
Figure 2. NIK Negatively Regulates IFN-I Induction
(A and B) WT orMap3k14–/– primary MEFs were infected with VSV (A) or SeV (B). The relative mRNA amount and protein concentration were determined by qPCR
and ELISA, respectively.
(C) qPCR analysis of relative Ifna and Ifnb mRNA amounts in WT and Map3k14–/– MEF cells stimulated with lipofectamine-transfected poly(I:C) (pIC) for the
indicated time periods.
(D–F) BMDMs derived from WT orMap3k14–/– mice were infected with SeV (D) or stimulated with LPS and poly(I:C) (E and F). Relative mRNA amounts (D and E)
and protein concentration (F) of IFN-b were determined by qPCR and ELISA, respectively.
(G) qPCR analysis of Ifnb mRNA expression in WT and NIKDT3 BMDMs stimulated with LPS or poly(I:C).
(H) qPCR analysis of Ifna and Ifnb mRNA expression in FLT3L-differentiated pDCs (F-pDCs) and cDCs (F-cDCs) and GM-CSF-differentiated cDCs (G-cDCs)
stimulated as indicated.
All qPCR data are presented as fold relative to the amount of an internal control, Actb. Data are representative of three to four independent experiments, and
statistical analyses represent variations in technical replicates. Data are presented as mean ± SD. *p < 0.05 and **p < 0.01. See also Figure S1.
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TLR Ligands
To examine whether NIK directly regulates IFN-I induction, we
infected the WT and NIK-deficient MEFs in vitro with two
different RNA viruses, VSV and Sendai virus (SeV). Compared
to the WT MEFs, the NIK-deficient MEFs were hyperresponsive
to both viruses in the induction of IFN-a and IFN-b at both the
mRNA and protein levels (Figures 2A and 2B). NIK deficiency
also promoted IFN-I induction by liposome-delivered poly(I:C),
a synthetic double-stranded RNA known to stimulate the RIG-I
signaling pathway when delivered into the cytoplasm by trans-
fection (Figure 2C).
Macrophages serve as an important cellular component in
innate immunity and respond to various microbial components,
such as viral RNA and bacterial lipopolysaccharides (LPS). We
therefore analyzed the effect of NIK deficiency on IFN-I induction
in bone-marrow-derivedmacrophages (BMDMs). NIK deficiency
did not influence BMDM differentiation (Figure S1B) but signifi-344 Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc.cantly promoted induction of Ifnb gene expression by SeV (Fig-
ure 2D) and VSV (Figure S1C). NIK deficiency also elevated
IFN-I induction by ligands for TLR4 (LPS), TLR3 [poly(I:C)],
TLR7 (R848), and TLR9 (CpG) (Figures 2E, 2F, and S1D). Further-
more, although IKKa has a positive role in IRF7-mediated IFN-a
induction in pDCs (Hoshino et al., 2006), the loss of the
IKKa-encoding gene Chuk in macrophages promoted IFN-b
induction by LPS (Figure S1E). As a complementary approach,
we employed a transgenic mouse expressing a stable form of
NIK lacking its TRAF3-binding motif (NIKDT3) (Sasaki et al.,
2008). The induction of Ifnb expression by LPS and poly(I:C) as
well as VSV was profoundly suppressed in the NIKDT3-express-
ing BMDMs (Figures 2G and S1F).
We next analyzed the role of NIK in IFN-I induction in DCs,
including FLT3 ligand (FLT3L)-induced plasmacytoid DCs
(pDCs) and conventional DCs (cDCs) as well as granulocyte
macrophage-colony stimulating factor (GM-CSF)-induced
cDCs. Interestingly, NIK deficiency did not promote IFN-a
Figure 3. NIK-Dependent Noncanonical NF-kB Signaling Negatively Regulates IFN-I Induction
(A) Immunoblot analysis of the indicated phosphorylated (P-) and total proteins in the cytoplasmic (CE) and nuclear (NE) extracts of WT andMap3k14–/– BMDMs
stimulated with LPS.
(B and C) Immunoblot analysis of the indicated proteins in the cytoplasmic (CE) and nuclear (NE) extracts of WT andMap3k14–/– MEFs infected with VSV or SeV
(B) or stimulated with lipofectamine-transfected poly(I:C) (C).
(D and E) Immunoblot analysis of the indicated proteins in the cytoplasmic (CE) and nuclear (NE) extracts of Map3k14–/– (D), Nfkb2lym1/+ (E), or their WT control
BMDMs stimulated with LPS and poly(I:C) as indicated.
(F) qPCR analysis of IfnbmRNA amounts (fold relative to the internal control ActbmRNA) of WT and Nfkb2lym1/+ BMDMs stimulated with LPS and poly(I:C). Data
are presented as mean ± SD, and statistical analyses represent variations in technical replicates. *p < 0.05 and **p < 0.01.
Data in all panels are representative of three independent experiments. See also Figures S2 and S3.
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Noncanonical NF-kB Regulates IFN-I inductioninduction in pDCs or FLT3L-induced cDCs, but it resulted in
hyperinduction of IFN-a and IFN-b in GM-CSF-differentiated
cDCs (Figure 2H). Collectively, these results suggest that NIK
functions as a potent negative regulator of IFN-I induction by
both RNA viruses and TLRs, although this function was not
seen in the FLT3L-induced DCs.
NIK Regulates IFN-I Induction via Activation of
Noncanonical NF-kB
To understand how NIK negatively regulates IFN-I induction, we
examined the effect of NIK deficiency on the activation of
signaling factors involved in this innate immune response. The
loss of NIK did not affect LPS-induced activation of TBK1 and
IKKε, as assessed by phospho-specific immunoblotting (IB)
assays (Figure 3A). The phosphorylation of IRF3 was also com-
parable between the WT and Map3k14–/– cells (Figure 3A).
Similar results were obtained with poly(I:C)-stimulated cells (Fig-
ure S2A). NIK deficiency also did not influence the activation of
MAP kinases (Figure S2B).NIK is a central mediator of the noncanonical NF-kB. Although
the role of noncanonical NF-kB in innate immunity is unclear, a
recent study indicates the induction of this pathway by inducers
of RIG-I (Liu et al., 2008). We found that infection of MEFs with
VSV or SeV led to the induction of NIK and nuclear expression
of p52 and RelB (Figure 3B). Furthermore, NIK deficiency abro-
gated the production and nuclear translocation of p52 and
partially inhibited the nuclear translocation of RelB. The virus-
induced NIK upregulation was readily detected at 9 hr (Fig-
ure 3B). An immunoblot with excessive cell lysates also revealed
the induction of NIK as early as 3 hr after viral infection as well as
a low basal amount of NIK in the WT MEFs (Figure S2C). Simi-
larly, liposome-transfected poly(I:C) stimulated the NIK protein
abundance and noncanonical NF-kB nuclear expression in WT
MEFs, but not inMap3k14–/– MEFs (Figure 3C). These molecular
events were associated with degradation of the NIK inhibitor
TRAF3 (Figure S2D). Thus, like the other known noncanonical
NF-kB stimuli, such as BAFF, lymphotoxin, and CD40 ligand,
RNA viruses stimulate the NIK pathway through induction ofImmunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc. 345
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Noncanonical NF-kB Regulates IFN-I inductionTRAF3 degradation. The relative slow kinetics of noncanonical
NF-kB induction by viruses and liposome-delivered poly(I:C)
(Figures 3B and 3C) was correlated with that of IFN-I induction
(Figures 2A–2C). Furthermore, NIK deficiency in MEFs did not
promote virus-induced phosphorylation of TBK1 or IRF3
(Figure S2E).
Because TLR ligands could induce rapid IFN-I expression in
macrophages, we were curious about their ability to stimulate
noncanonical NF-kB signaling under such conditions. Neither
LPS nor poly(I:C) induced the accumulation of NIK or generation
of p52 (Figure 3D). Interestingly, however, macrophages had
basal amounts of NIK expression and p52 production, and
the production of p52 was blocked in the Map3k14–/– macro-
phages (Figure 3D). Furthermore, p52 was detected in both the
cytoplasm and the nucleus of the WT cells, and the nuclear
translocation of p52 was further induced upon LPS and poly(I:C)
stimulation (Figure 3D). Although the expression of RelB was
comparable in theMap3k14–/– macrophages, its nuclear translo-
cation was reduced in thesemutant cells (Figure 3D). In contrast,
the induction of canonical NF-kB members p50 and RelA was
not influenced by NIK deficiency (Figure 3D). These results
suggest that p100 processing may be stimulated during macro-
phage differentiation, thereby contributing to the negative regu-
lation of TLR-stimulated IFN-I expression.
To further examine the role of p100 processing in IFN-I gene
induction, we employed a mouse strain carrying an Nfkb2 gene
mutation (called lym1) that causes theproductionof a nonproces-
sible form of p100 resulting from the loss of its C-terminal phos-
phorylation site (Tucker et al., 2007). Both homozygous
Nfkb2lym1/lym1 and heterozygous (Nfkb2lym1/+) mice have severe
defect in p52 generation and immune functions (Tucker et al.,
2007). Because the efficiency of breeding Nfkb2lym1/lym1 mice
was low, we used the Nfkb2lym1/+ heterozygous BMDMs in the
experiments. Like NIK deficiency, the Nfkb2 lym1 mutation did
not appreciably influence the differentiation of macrophages
(data not shown). We found that p52 was produced in the WT
macrophages but barely in the Nfkb2lym1/+ macrophages (Fig-
ure 3E). The nuclear translocation of RelB was also attenuated
in the Nfkb2lym1/+ cells (Figure 3E). The activation of canonical
NF-kB members p50 and RelA was either not affected or only
weakly reduced in the Map3k14–/– or Nfkb2lym1/+ macrophages
(Figures 3D and 3E). Moreover, the defect in noncanonical
NF-kBactivation in theNfkb2lym1/+macrophageswas associated
with a striking increase in the induction of Ifnb gene expression
(Figure 3F). Consistent with the macrophage results, the
Nfkb2lym1/lym1MEFswere hyperresponsive to stimulation by lipo-
some-transfectedpoly(I:C) in IFN-I gene induction (FigureS3).We
also found that preincubation of WTMEFs, but notNfkb2lym1/lym1
MEFs, with a noncanonical NF-kB inducer (anti-LTbR) signifi-
cantly suppressed IFN-I gene induction (Figure S3). These results
further confirmacrucial role for the noncanonicalNF-kBsignaling
pathway in the negative control of IFN-I gene induction.
Hematopoietic Cytokines Stimulate Noncanonical
NF-kB along with Innate Immune Cell Differentiation
The finding that NIK controlled the production of p52 in macro-
phages suggested an intriguing possibility that NIK might
regulate noncanonical NF-kB signaling during macrophage dif-
ferentiation. Because macrophage colony stimulating factor346 Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc.(M-CSF) receptor (M-CSFR) is the primary receptor that medi-
ates macrophage differentiation from bone marrow cells (Inaba
et al., 1993), we examined the possible role of M-CSFR in the
induction of noncanonical NF-kB signaling. Cultivation of bone
marrow inM-CSF-containingmedium led to the potent induction
of p100 and RelB protein amount (Figure 4A). M-CSF also
induced the nuclear translocation of both p52 and RelB. Further-
more, the induction of p52 and (to a lesser extent) RelB was
dependent on NIK (Figure 4A). This result suggested a role for
M-CSF in the induction of noncanonical NF-kB signaling along
with themacrophagedifferentiation. Indeed, theM-CSF-induced
BMDM differentiation was also associated with accumulation of
NIK and reduction in the NIK negative regulators TRAF2 and
TRAF3 (Figure 4B). The E3 ubiquitin ligases cIAP1 and cIAP2,
which are involved in the degradation of TRAF2 and TRAF3 (Val-
labhapurapu et al., 2008), were also induced (Figure 4B).
To further examine the capability of M-CSFR to induce nonca-
nonical NF-kB activation, we stimulated bone marrow cells with
M-CSF in a time course and analyzed the degradation of TRAF2
and TRAF3 and accumulation of NIK, crucial events of nonca-
nonical NF-kB signaling (Sun, 2012). M-CSF stimulated gradual
loss of both TRAF2 and TRAF3 and accumulation of NIK (Fig-
ure 4C). These signaling events peaked around 12 hr and
reversed by 24 hr after M-CSF stimulation (Figure 4C). However,
more persistent signaling could be achieved upon replacement
of medium with newly added M-CSF (Figures S4A and S4B).
Parallel experiments revealed that M-CSF stimulated conjuga-
tion of K48-linked polyubiquitination chains to TRAF2 and
TRAF3 (Figure 4D). CD40 ligand-induced degradation of
TRAF2 and TRAF3 is thought to involve their recruitment to the
signaling receptor CD40, along with the E3 ubiquitin ligases
c-IAP1 and c-IAP2 (Vallabhapurapu et al., 2008). Similarly,
M-CSFR also recruited TRAF2 and TRAF3 (Figure 4E) as well
as c-IAPs (Figure S4C) upon M-CSF stimulation. In addition,
the M-CSF-stimulated degradation of TRAF2 and TRAF3 was
blocked by a small molecule c-IAP inhibitor, Smac (Figure S4D).
These results suggest that M-CSFR mediates noncanonical
NF-kB signaling via induction of ubiquitin-dependent degrada-
tion of TRAF2 and TRAF3 and accumulation of NIK.
We next examined the noncanonical NF-kB activation along
with DC differentiation driven by GM-CSF and FLT3L. Similar
to M-CSF, GM-CSF stimulated NIK-dependent activation of
p52 and RelB during DC differentiation (Figure 4F). In sharp
contrast, FLT3L-mediated DC differentiation did not stimulate
noncanonical NF-kB activation (Figure 4F). To further confirm
this finding, we examined the noncanonical NF-kB activation
by GM-CSF and FLT3L in a DC cell line stably expressing murine
FLT3 (D2SC-mFLT3). As seen in the primary DCs, GM-CSF but
not FLT3L stimulated the nuclear translocation of p52 and
RelB (Figure 4G). GM-CSF also induced partial loss of TRAF3
(Figure 4G), although it was less profound than that stimulated
by M-CSF (Figure 4C). These findings suggest that GM-CSF,
but not FLT3L, stimulates the noncanonical NF-kB signaling,
thus explaining the different function of NIK in DCs differentiated
by GM-CSF and FLT3L (Figure 2H).
Noncanonical NF-kB Suppresses IFN-I Gene Induction
The data described above strongly suggest the involvement of
noncanonical NF-kB members in the negative regulation of
Figure 4. M-CSF Induces Noncanonical
NF-kB Signaling
(A and B) Immunoblot analysis of the indicated
proteins in the cytoplasmic (CE) and nuclear (NE)
extracts of bone marrow (BM) cells or M-CSF-
induced BMDMs (BMM) from WT andMap3k14–/–
mice.
(C) Immunoblot analysis of the indicated proteins
in whole-cell lysates of WT or Map3k14–/– bone
marrow cells stimulated with M-CSF for the indi-
cated time points.
(D) Bone marrow cells were stimulated with
M-CSF in the presence of the proteasome inhibitor
MG132. TRAF2 and TRAF3 were immuno-
precipitated from denatured cell lysates, and
ubiquitinated TRAF2 and TRAF3 was detected by
immunoblot via an antibody detecting K48-linked
polyubiquitin chains.
(E) WT bone marrow cells were stimulated with
M-CSF in the presence of the proteasome inhibitor
MG132. Whole-cell lysates were subjected to
M-CSFR IP followed by detecting M-CSFR-
associated TRAF2 and TRAF3 by IB (top two
panels). Cell lysates were also subjected to direct
IB (lower four panels).
(F) Immunoblot analysis of the indicated proteins
in the cytoplasmic (CE) and nuclear (NE) extracts
of FLT3L- or GM-CSF-generated dendritc cells
from WT and Map3k14–/– mice.
(G) D2SC/1 dendritic cell line constituted with
FLT3 (D2SC/1-FLT3) was stimulated with GM-
CSF or FLT3L as indicated and subjected to
immunoblot analyses.
Data are representative of two to three indepen-
dent experiments. See also Figure S4.
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using BMDMs derived from a mutant mouse (Nfkb2xdr) deficient
in NF-kB2 expression because of a splicing-disruptive Nfkb2
gene mutation (Miosge et al., 2002). Consistent with the
previous study (Miosge et al., 2002), BMDMs from homozygous
Nfkb2xdr/xdr mice lack both p100 and p52 (Figure 5A). Unlike the
Map3k14–/– and Nfkb2lym1/+ BMDMs, the Nfkb2xdr/xdr BMDMs
did not have attenuated nuclear translocation of RelB; rather,
they had elevated nuclear translocation of RelB, which was
apparently because of the loss of the RelB inhibitor p100 (Fig-
ure 5A). The Nfkb2xdr/xdr macrophages also had competent
nuclear translocation of the canonical NF-kB RelA (Figure 5A).
Thus, these mutant cells allowed us to specifically address the
role of p52 in the regulation of Ifnb induction. Despite their high
amounts of nuclear RelB, the Nfkb2xdr/xdr macrophages were
hyperresponsive to LPS and poly(I:C) in the induction of Ifnb
gene expression (Figure 5B). Similar results were obtained by
stimulating Nfkb2xdr/xdr MEFs with the RIG-I stimulator, lipo-
some-delivered poly(I:C) (Figure 5C). Parallel experiments re-
vealed that loss of RelB also caused hyperinduction of Ifnb
gene expression (Figure 5D). These findings suggest that nega-
tive regulation of IFN-I gene induction requires both of the non-
canonical NF-kB members p52 and RelB.
To further examine the role of noncanonical NF-kB in the regu-
lation of Ifnb expression, we examined the effect of different
NF-kB members on the Ifnb promoter activity via luciferase
reporter gene assays in transiently transfected HEK293 cells.As expected, the canonical NF-kBmember RelA potently syner-
gized with the IRF3 in the induction of Ifnb promoter (Figure 5E).
Expression of p50 further promoted the induction of Ifnb
promoter. In contrast, expression of p52 or RelB led to the inhi-
bition of RelA-IRF3-stimulated Ifnb promoter activation (Fig-
ure 5E). We also examined whether overexpressed p52 or
p100 inhibited the induction of endogenous Ifnb gene expres-
sion. Interestingly, reconstitution of the Nfkb2xdr/xdr MEFs with
either p52 or p100 led to efficient inhibition of Ifnb induction (Fig-
ure 5F). Furthermore, expression of a processing-defective p100
mutant, p100SSAA (Xiao et al., 2001), did not appreciably inhibit
the Ifnb gene induction (Figure 5F). Parallel immunoblot analyses
revealed comparable amounts of expression of p100, p52, and
p100SSAA (Figure 5G). These data further emphasize a negative
role for the noncanonical NF-kB members in the regulation of
Ifnb induction.
Noncanonical NF-kB Suppresses the Binding of RelA to
the Ifnb Promoter
Signal-induced Ifnb expression requires recruitment of a number
of transcription factors, including IRF3 and canonical NF-kB, to
the positive regulatory domains (PRD) of the Ifnb promoter
(Bartlett et al., 2012; Falvo et al., 2000; Panne et al., 2007;
Wang et al., 2010). To elucidate the mechanism by which nonca-
nonical NF-kB suppresses Ifnb induction, we examined the
effect of noncanonical NF-kB deficiency on the recruitment of
IRF3 and canonical NF-kB members to the Ifnb promoter.Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc. 347
Figure 5. Noncanonical NF-kB Members Suppress IFN-I Induction
(A) Immunoblot analysis of the indicated proteins in the cytoplasmic (CE) and nuclear (NE) extracts of WT or Nfkb2xdr/xdr BMDMs stimulated with LPS and
poly(I:C).
(B) qPCR analysis of relative amounts of Ifnb mRNAs (fold of the internal control Actb mRNA) in the WT and Nfkb2xdr/xdr BMDMs stimulated with LPS and
poly(I:C) (pIC).
(C and D) qPCR analysis of relative amounts of IfnbmRNA in xdr/xdr and WT control MEFs (C) or Relb–/– and WT control MEFs (D) stimulated with lipofectamine-
transfected poly(I:C).
(E) HEK293 cells were transfected with an Ifnb-luciferase reporter plasmid in the presence (+) or absence (–) of the indicated empty vector or expression plasmids.
Luciferase assays were performed as fold based on empty vector group 36 hr after transfection.
(F and G) Nfkb2xdr/xdr MEFs were reconstituted with GFP, p100, p52, and p100SSAA. The cells were either not treated (NT) or stimulated with lipofectamine-
transfected poly(I:C) and subjected to qPCR (F) or IB (G) analysis.
Data in (E) and (F) are presented as mean ± SD, and statistical analyses represent variations in technical replicates. *p < 0.05 and **p < 0.01. Data are repre-
sentative of two to three independent experiments.
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deficiency or the Nfkb2 lym1 mutation did not affect the recruit-
ment of IRF3 to the Ifnb promoter after LPS or poly(I:C) stimula-
tion (Figure S5A). In contrast, these genetic alterations in the
noncanonical NF-kB pathway potently enhanced the recruit-
ment of the canonical NF-kB RelA to the Ifnb promoter (Figures
6A, S5B, and S5C). Similar results were obtained with MEFs
stimulated with liposome-transfected poly(I:C) (Figure S5D). On
the other hand, the NIK deficiency and Nfkb2 lym1 mutation
had little or no effect on the binding of the other canonical
NF-kB subunits, p50 and c-Rel (Figures 6A and S5C). We found
that the noncanonical NF-kB members p52 and RelB were also
recruited to the Ifnb promoter in response to LPS and poly(I:C)
stimulation, which was greatly attenuated in the NIK-deficient
andNfkb2lym1/+ cells (Figures 6A and S5C). In linewith these find-
ings, the BMDMs derived from the NIKDT3 transgenic mice,
which overexpressed a stabilized form of NIK, NIKDT3, had
increased recruitment of p52 and RelB and decreased recruit-
ment of RelA to the Ifnb promoter (Figures 6B and S5B). These348 Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc.findings have important implications, because RelA has been
implicated as an important transactivator of IFN-I (Pe´rez de
Diego et al., 2010;Wang et al., 2010). Indeed, the RelA deficiency
in MEFs reduced the induction of Ifna and Ifnb (Figure S5E).
The results described above indicated that the noncanonical
NF-kB members might inhibit the binding of RelA to the Ifnb
promoter. We further examined this possibility by performing
EMSA to test whether p52 and RelB inhibits the binding of
RelA to the Ifnb NF-kB-binding site. When coexpressed in
HEK293 cells, p52 and RelB dose-responsively suppressed
the binding of RelA to the Ifnb kB probe (Figure S5F). Moreover,
this experiment also revealed that the p52-RelB dimer binds to
the Ifnb kB probe more strongly than RelA (Figure S5F). As a
complementary approach, we examined whether loss of p52
promoted the binding of RelA to the Ifnb promoter by ChIP
assays. Indeed, the p52 deficiency in the Nfkb2xdr/xd macro-
phages significantly promoted the binding of RelA to the Ifnb
promoter (Figure 6C). Interestingly, the p52 deficiency also
attenuated the binding of RelB to the Ifnb promoter (Figure 6C),
Figure 6. RelA Physically Interacts with JMJD2A and Binds to Ifnb Promoter in a Manner that Is Suppressed by Noncanonical NF-kB
BMDMs prepared from Map3k14–/– (A), NIKDT3 transgenic (B), or Nfkb2xdr/xdr (C) mice and their WT littermate controls were stimulated for 1 hr with LPS or
poly(I:C). ChIP assays were performed and quantified by qPCR to detect the binding of NF-kB family members to the Ifnb promoter. Data are presented as
percentage of the total input DNA. Data are mean ± SD and representative of two to three independent experiments, and statistical analyses represent variations
in technical replicates. *p < 0.05 and **p < 0.01. See also Figure S5.
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proteins for the DNA-binding function of RelB (Fusco et al.,
2008). These results indicate that the noncanonical NF-kB
members may compete with RelA for binding to the kB site at
the Ifnb promoter.
Noncanonical NF-kB Appears to Regulate Histone
Modifications in the Ifnb Promoter
Histone modifications represent a critical epigenetic mechanism
that regulates gene transcription (Berger, 2002). Some histone
modifications, including dimethylation of H3K9 (H3K9me2), tri-
methylation of H3K9 (H3K9me3), and trimethylation of H3K27
(H3K27me3), are associated with gene repression, whereas
other modifications, such as H3K4me3 and H3 acetylation
(H3Ac), are associated with active chromatin structures (Cedar
and Bergman, 2009). To obtain more insight into the mechanism
by which noncanonical NF-kB suppresses IFN-I induction, we
performed ChIP assays to examine histone modifications in
the Ifnb promoter. Stimulation of WT macrophages with LPS
and poly(I:C) led to the induction of H3K4me3 and H3Ac,
coupled with reduction in H3K9me2 and H3K9me3, at the Ifnb
promoter (Figures 7A and S6A). The abundance of H3K27me3
was also moderately increased. Similar amounts of H3K9me2
and H3K27me3 were detected in the WT and NIK-deficient
macrophages (Figure 7A). Interestingly, NIK deficiency pro-
foundly promoted the loss of H3K9me3 after stimulation with
LPS or poly(I:C) (Figures 7A and S6A). In contrast, the NIK-defi-
cient macrophages had a significant increase in the activating
type of histone modifications H3Ac and H3K4me3. Similar
results were obtained with the LPS- and poly(I:C)-stimulated
Nfkb2lym1/+ macrophages (Figure S4B) as well as Map3k14–/–
MEFs stimulated by liposome-transfected poly(I:C) (Figure S6C).We next employed the NIKDT3 transgenic mice to examine
the effect of NIK overexpression on the histone modifications
in the Ifnb promoter. The NIK overexpression had little or no
effect on the amount of H3K9me2 and H3K27me3 but signifi-
cantly attenuated the loss of H3K9me3 and induction of H3Ac
in cells treated with LPS and poly(I:C) (Figures 7B and S6D).
The NIK overexpression also attenuated poly(I:C)-mediated
induction of H3K4me3 (Figures 7B and S6D). These results
indicate that NIK and the noncanonical NF-kB pathway possibly
regulate histone modifications, particularly H3K9me3 and H3Ac,
at the Ifnb promoter.
JMJD2A Engages the Ifnb Promoter in a NIK-Regulated
Manner
Histone methylations are conversely regulated by lysine methyl-
transferases and lysine demethylases (Black et al., 2012). In
particular, the lysine methyltransferase G9a and the Jumonji
domain 2 (JMJD2) family of lysine demethylases play an impor-
tant role in regulating the methylation status of H3K9 (Gray et al.,
2005; Tachibana et al., 2001; Whetstine et al., 2006). Our finding
that the noncanonical NF-kB pathway inhibited the TLR-stimu-
lated erase of H3K9me3 at the Ifnb promoter indicated a role
for this pathway in regulating the recruitment of a lysine methyl-
transferase or a lysine demethylase. We found that the WT and
Map3k14–/– macrophages had a similar amount of G9a binding
to the Ifnb promoter (Figure 7C). Interestingly, NIK deficiency
significantly promoted the recruitment of JMJD2A, although
not the other JMJD2 members, to the Ifnb promoter (Figures
7C and S6E). Similar results were obtained with Map3k14–/–
MEFs (Figure S6C). Consistently, the NIK overexpression in the
NIKDT3 transgenic macrophages inhibited the TLR-stimulated
binding of JMJD2A to the Ifnb promoter (Figures 7D and S6E).Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc. 349
Figure 7. NIK Regulates Histone Modifications and JMJD2A Binding at the Ifnb Promoter
(A–D) BMDMs derived from Map3k14–/– (A and C), NIKDT3 transgenic (B and D), or their WT control mice were stimulated with LPS or poly(I:C) for 1 hr. ChIP
assays were performed to detect histone modifications (A and B) and binding of the indicated factors (C and D) at the Ifnb promoter. The y axis is percentage (%)
based on total H3 for (A) and (B), and percentage (%) based on total input DNA for (C) and (D). Data are representative of three independent experiments, and
statistical analyses represent variations in technical replicates.
(E)WT andMap3k14–/– BMDMswere pretreated for 12 hr with 20mMof a JMJD2 inhibitor (5-carboxy-8HQ) and then stimulated with LPS or poly(I:C) as indicated.
The relative amount of Ifnb mRNAs were quantified by qPCR and presented as fold relative to the internal Actb mRNA control.
(F) WT andMap3k14–/– BMDMs were infected with two different JMJD2A shRNAs or a nonsilencing control shRNA and then stimulated with LPS and poly(I:C) as
indicated. The relative amount of Ifnb mRNAs were quantified by qPCR and presented as fold relative to the internal Actb mRNA control.
Data are mean ± SD and representative of two to three independent experiments, and statistical analyses represent variations in technical replicates. *p < 0.05
and **p < 0.01. See also Figures S6 and S7.
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the recruitment of JMJD2A to the Ifnb promoter, we found that
RelA and JMJD2A physically interacted under both transfection
(Figure S7A) and endogenous conditions (Figure S7B), the latter
of which occurred in response to stimulation by LPS or poly(I:C).
Under the same conditions, several other NF-kB members did
not bind JMJD2A (Figure S7C). Furthermore, RelA deficiency
attenuated the engagement of JMJD2A to the Ifnb promoter
and inhibited the erase of H3K9me3 in cells stimulated with
lipofectamine-delivered poly(I:C) (Figure S7D). These results
suggest a possibility that RelA may recruit JMJD2A to the Ifnb
promoter, although this idea is still quite preliminary and requires
additional explorations. Nevertheless, JMJD2A appeared to
have an important role in mediating IFN-I induction, because350 Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc.JMJD2 inhibition by a pharmacological inhibitor, 5-carboxy-
8HQ (Figure 7E), or JMJD2A silencing by shRNA (Figures S7E
and 7F) inhibited the induction of Ifnb expression in both the
WT and Map3k14–/– macrophages. The JMJD2A silencing also
prevented the LPS- and poly(I:C)-stimulated downregulation of
H3K9me3 at the Ifnb promoter (Figure S7F). Similar results
were obtained with JMJD2A knockdown MEFs (Figures S7G
and S7H). Furthermore, reconstitution of the JMJD2A-silenced
cells with an RNAi-resistant form of JMJD2A, but not a cata-
lytically inactive JMJE2A mutant (H188A), restores the IFN-I
induction (Figures S7G and S7H). These results indicate that
noncanonical NF-kB may regulate the recruitment of JMJD2A
to the Ifnb promoter and modulate histone modifications, which
contribute to the negative regulation of IFN-I induction.
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The noncanonical NF-kB pathway has so far been linked to the
regulation of specific adaptive immune functions, such as
lymphoid organogenesis and B cell survival. However, emerging
evidence suggests that this pathway is also activated along with
viral infection, although the functional significance in antiviral
immunity has remained unclear (Manches et al., 2012; Ru¨ckle
et al., 2012). The data presented in this study demonstrated an
unexpected role for the noncanonical NF-kB pathway in the
regulation of antiviral innate immunity. We obtained genetic
evidence that this signaling pathway controls the magnitude of
IFN-I induction by RNA viruses and TLR ligands.
We found that both VSV andSeV could stimulate the activation
of noncanonical NF-kB pathway. Although MEFs had a very low
basal amount of NIK, the infection with VSV or SeV led to
profound upregulation of NIK. These RNA viruses induced the
degradation of the NIK inhibitor, TRAF3, coupled with accumula-
tion of NIK and induction of p100 processing. The virus-induced
NIK upregulation and noncanonical NF-kB activation probably
contribute to the suppression of IFN-I induction, as suggested
by results obtainedwith differentMEFs lacking NIK or p52. Infec-
tion of a lung epithelial cell line with the respiratory syncytial virus
also induces NIK expression and p52 production (Choudhary
et al., 2005). Although precisely how viruses stimulate the NIK
pathway remains unclear, the RNA helicase RIG-I appears to
be involved (Liu et al., 2008). Consistently, we found that lipofect-
amine-delivered poly(I:C), a known stimulator of RIG-I, induced
NIK stabilization and p100 processing. Furthermore, both viral
infections and poly(I:C) transfection induced TRAF3 degrada-
tion, although the underlying mechanism is incompletely under-
stood. The c-IAP1 and c-IAP2 E3 ubiquitin ligases are known to
mediate TRAF3 ubiquitination and degradation stimulated by the
typical noncanonical NF-kB inducers LTbR and CD40 (Ha¨cker
et al., 2011). The c-IAPs have also been shown to mediate
RIG-I- and virus-induced TRAF3 ubiquitination (Mao et al.,
2010), although another E3 ligase, Triad3A, has been suggested
to mediate the degradation of TRAF3 in virus-infected cells
(Nakhaei et al., 2009). It remains to be examined whether these
E3 ubiquitin ligases mediate virus-induced NIK induction and
p100 processing.
Compared to MEFs, macrophages had a much higher basal
amount of NIK, which explains why the NIK deficiency in macro-
phages promotes the rapid induction of IFN-I by TLR ligands. We
discovered an unexpected pathway of noncanonical NF-kB
signaling triggered by M-CSF, a cytokine that mediates the
differentiation and growth of macrophages. M-CSF stimulated
the recruitment of TRAF2 and TRAF3, as well as the E3 ubiquitin
ligases c-IAP1 and c-IAP2, to its receptor, M-CSFR, which was
associated with K48 ubiquitination and degradation of these
TRAF molecules and concomitant accumulation of NIK. Thus,
as implicated for CD40 (Vallabhapurapu et al., 2008), M-CSFR
appeared to mediate the activation of noncanonical NF-kB
signaling via destruction of TRAF2 and TRAF3 in the receptor
complex. Like M-CSF, GM-CSF stimulated the activation of
noncanonical NF-kB, which appeared to also involve degrada-
tion of TRAF3. Consistently, NIK and the nocanonical NF-kB
pathway also inhibit IFN-I induction in GM-CSF-differentiated
DCs. On the other hand, loss of NIK did not enhance IFN-I induc-tion in FLT3L-differentiated DCs. This was correlated with the
inability of FLT3L to induce noncanonical NF-kB activation.
TBK1 and IKKε are known as innate immune regulators that
mediate induction of IFNs in response to TLR stimulation and
viral infection (Fitzgerald et al., 2003; Sharma et al., 2003). Our
data revealed that the noncanonical NF-kB deficiency did not
promote the activation of TBK1 and IKKε or their downstream
transcription factor IRF3. Instead, our data suggest a crosstalk
between the canonical and noncanonical NF-kB pathways, in
which the noncanonical NF-kB appeared to repress the binding
of the canonical NF-kB RelA to the Ifnb promoter. This mecha-
nism of noncanonical NF-kB function was demonstrated by
both EMSA and ChIP assays as well as by luciferase reporter
assays.
Our data also suggest a role for the noncanonical NF-kB
pathway in the regulation of histone modifications at the Ifnb
promoter, although this line of studies is somewhat preliminary
and requires additional experiments for understanding the
underlying mechanism. We found that genetic deficiencies in
NIK or the noncanonical NF-kB p52 promoted the induction of
the transcriptionally active histone mark H3Ac and the erasure
of the repressive mark H3K9me3. The acetylation and methyl-
ation at the lysines of histones are mutually exclusive (Wang
et al., 2008), so it is possible that the upregulation of H3Ac in
Map3k14–/– and Nfkb2lym1/+ macrophages was a result of down-
regulation of methylation. The H3K9me3 downregulation in the
mutant macrophages was associated with enhanced recruit-
ment of a lysine demethylase, JMJD2A. To date, the function
of JMJD2A has been mainly studied in cancer cell lines and
linked to cancer cell growth, but its role in the regulation of immu-
nity has remained unclear. Our data indicate a role for JMJD2A in
the regulation of IFN-I in macrophages. One intriguing possibility
is that RelA binds to JMJD2A and recruits this demethylase to
the Ifnb promoter. Our data indeed suggest the physical interac-
tion between RelA and JMJD2A, although additional studies are
required to examine whether this interaction contributes to the
histone modification at the Ifnb promoter.
In summary, we have identified the noncanonical NF-kB
pathway as an important mechanism that controls IFN-I induc-
tion and antiviral immunity. Our findings provide functional
insight into the induction of this signaling pathway alongwith viral
infection. We have also provided genetic evidence that the
noncanonical NF-kB pathway is stimulated along with innate
immune cell differentiation, providing an example for how a
differentiation-associated signaling event programs cells for
the regulation of innate immunity. Our studies have also identi-
fied a potential function for the noncanonical NF-kB in regulating
histone modifications in the Ifnb promoter. These findings not
only provide important insight into the mechanism regulating
IFN-I induction but also assign a crucial function of the nonca-
nonical NF-kB pathway.
EXPERIMENTAL PROCEDURES
Mice
Nfkb2lym1 mutant mice were provided by R. Starr and TheWalter and Eliza Hall
Institute of Medical Research. The Nfkb2xdr/xdr mice were provided by The
Australian National University and are available from the Australian Phenome
Bank (ID #93). NIKDT3-floxed mice (Jackson Lab) were crossed with lysozyme
2 Cre transgenic mice (Lyz2-Cre, Jackson Lab) to produce age-matchedImmunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc. 351
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Noncanonical NF-kB Regulates IFN-I inductionNIKDT3fl/fllyz2+/+ (termed WT) and NIKDT3fl/fllyz2Cre/+ (termed NIKDT3) mice
for experiments. The Map3k14–/– mice were provided by Amgen and the
Relb–/– mice were from Bristol-Myers Squibb Pharmaceutical Research Insti-
tute. In some experiments, Map3k14–/– mice were further crossed to the
Rag1–/– or Rag1–/–-Ifnar1–/– background. The mice were maintained in spe-
cific-pathogen-free facility of The University of Texas MD Anderson Cancer
Center, and all animal experiments were conducted in accordance with proto-
cols approved by the Institutional Animal Care and Use Committee.
Viral Infection
For gene induction and signaling analyses, MEFs were seeded into 12-well
plates (3.75 3 105 cells per well) and infected with VSV-AV1 mutant or SeV
strains in serum-free medium for 1 hr. The cells were washed once and
cultured in growth medium for the indicated time periods and then collected
for immunoblot or qPCR assays, and the supernatant were used for ELISA.
To determine the infection efficiency, MEFs were infected with VSV-GFP for
12 hr, and the infected (GFP+) cells were visualized under a fluorescence
microscope and quantified by flow cytometry. For mouse infection, age-
matched (8 weeks old) mutant and WT control mice were housed in microiso-
later cages in a biosafety level 2 facility and infected i.v. with VSV (23 107 PFU
per mouse in 250 ml). The infected mice were monitored for lethality for up to
8 days or, where indicated, bled for collecting blood or perfused with sterile
phosphate-buffered saline (PBS) for collecting tissues. The sera were used
for measuring IFNs by ELISA, and the tissues were homogenized for deter-
mining the VSV titers in the supernatants via BHK cells.
Flow Cytometry and Cell Sorting
Flow cytometry and cell sorting were performed with FACSAria (BD
Biosciences). The fluorescence-labeled antibodies that were used included
PE-conjugated anti-F4/80 (eBioscience, BM8) and anti-B220 (BD Biosci-
ences, RA3-6B2) and APC-conjugated anti-CD11b (eBioscience, M1/70).
Cells and Stimulation
Bone marrows were prepared from the femurs of adult mice and cultured in a
MCSF-conditional medium for BMDM differentiation as previously described
(Waterfield et al., 2003). To prepare FL3L-induced DCs (called F-DCs), we
cultured the bone marrow cells in RPMI medium supplemented with FLT3L
(50 ng/ml) for 7 days and then purified the F-cDC and F-pDC by flow cytomet-
ric cell sorting based on specific surface markers, CD11c+CD11b+B220– for
F-cDCs and CD11c+CD11b–B220+ for F-pDCs. GM-CSF-induced DCs were
prepared by the same procedure, except that the cells were cultured in the
presence of GM-CSF (5 ng/ml). To prepare primary MEFs, we bred hetero-
zygous mice for obtaining the KO and WT embryos from the same pregnant
female mice (Chang et al., 2011). Immortalized Rela/ MEFs were provided
by L.-F. Chen and P. Chiao. All MEFs, except the Rela/ MEFs, were used
as primary cell culture. The MEFs, BMDMs, and DCs were starved overnight
in medium supplemented with 0.5% FCS before being stimulated with LPS
(1 mg/ml for immunoblot experiments and 100 ng/ml for cytokine induction
experiments), poly(I:C) (20 mg/ml), lipofectamine-transfected poly(I:C)
(20 mg/ml), CpG-A (25 mM), or R848 (1 mg/ml) for the indicated times. Total
and subcellular extracts were prepared for immunoblot assays, and total
RNA was prepared for qPCR assays.
shRNA-Mediated Gene Silencing
The pGIPZ lentiral vectors encoding shRNAs for NIK, JMJD2A, or a nonsilenc-
ing control shRNA were obtained from Open Biosystems, and the lentiral
vector pLKO.1 encoding NIK shRNAs or the control luciferase shRNA were
from Sigma. To produce lentiviral particles, the lentiviral vectors were trans-
fected into HEK293T cells (via calcium method) along with the packaging
vectors psPAX2 and pMD2 (Chang et al., 2011). MEFs or the dendritic cell
line D2SC/1 were infected with the lentiviruses and selected with puromycin
(for pLKO.1 and pGIPZ vectors) or by flow cytometric cell sorting based on
GFP (for pGIPZ; pGIPZ carries both the puromycin-resistance gene and the
GFP gene).
Real-Time Quantitative RT-PCR
Total RNA was isolated with TRI reagent (Molecular Research Center) and
subjected to cDNA synthesis with RNase H-reverse transcriptase (Invitrogen)352 Immunity 40, 342–354, March 20, 2014 ª2014 Elsevier Inc.and oligo (dT) primers. qPCR was performed in triplicates, with iCycler
Sequence Detection System (Bio-Rad) and iQTM SYBR Green Supermix
(Bio-Rad). The expression of individual genes was calculated by a standard
curve method and normalized to the expression of Actb. The gene-specific
PCR primers (all for mouse genes) are shown in Table S1.
Chromatin Immunoprecipitation Assays
BMDMs (63 107) were stimulated for 1 hr with LPS or poly(I:C), or MEFs were
stimulated with poly(I:C) plus lipofectamine for 9 hr. Then, these cells were
fixed with 1% formaldehyde and sonicated as previously described (Nelson
et al., 2006). Lysates (from 2 3 107 cells in 3 ml) were subjected to immuno-
precipitation with the indicated antibodies, and the precipitated DNA was
then purified by Qiaquick columns (QIAGEN) and quantified by qPCR via a
pair of primers that amplify the PRDIII-II region of the Ifnb promoter (Table
S1). The precipitated DNA is presented as percentage of the total input DNA
(y axis). For histonemodification analyses, the DNA bound bymodified histone
3 is presented as percentage of total histone 3-bound DNA. The repeated
results of ChIP assays are presented in Supplemental Figures.
Statistical Analysis
Prism software was used for two-tailed unpaired t tests. p values <0.05 and
<0.01 are considered significant and very significant, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
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